82 related articles for article (PubMed ID: 6536234)
41. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
42. Demonstration of thymus-leukemia (TL) antigens on mitochondria of lymphoid cells by immunoelectron microscopy.
Jeng MW; Finegold MJ; Basch RS; Lamm ME
Lab Invest; 1978 Jan; 38(1):41-4. PubMed ID: 74453
[TBL] [Abstract][Full Text] [Related]
43. In vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. III. Spontaneous and natural cytotoxic effector cells.
Herbert AG; Le Gros GS; Bidawid S; Watson JD
Immunology; 1984 Feb; 51(2):377-85. PubMed ID: 6607213
[TBL] [Abstract][Full Text] [Related]
44. Functional heterogeneity of helper T cells: two distinct helper T cells are required for the production of T cell growth factor.
Larsson EL
J Immunol; 1982 Feb; 128(2):742-5. PubMed ID: 6798123
[TBL] [Abstract][Full Text] [Related]
45. MALA-1: a surface antigen expressed on activated murine T and B lymphocytes.
Takei F
J Immunol; 1984 Jul; 133(1):345-50. PubMed ID: 6609986
[TBL] [Abstract][Full Text] [Related]
46. Monoclonal antibody 8H9 targets a novel cell surface antigen expressed by a wide spectrum of human solid tumors.
Modak S; Kramer K; Gultekin SH; Guo HF; Cheung NK
Cancer Res; 2001 May; 61(10):4048-54. PubMed ID: 11358824
[TBL] [Abstract][Full Text] [Related]
47. [Monoclonal antibodies against surface antigens of cancer cells. Experimental preparation for early diagnosis and immuno-assisted therapy].
Zenner HP
Fortschr Med; 1983 May; 101(19):891-2, 894. PubMed ID: 6873841
[TBL] [Abstract][Full Text] [Related]
48. Thymus-leukemia (TL) antigens of the mouse. Analysis of TL mRNA and TL cDNA TL+ and TL- strains.
Chen YT; Obata Y; Stockert E; Old LJ
J Exp Med; 1985 Oct; 162(4):1134-48. PubMed ID: 3840195
[TBL] [Abstract][Full Text] [Related]
49. Anti-tumor immunity induced by an anti-idiotype antibody mimicking human Her-2/neu.
Mohanty K; Saha A; Pal S; Mallick P; Chatterjee SK; Foon KA; Bhattacharya-Chatterjee M
Breast Cancer Res Treat; 2007 Jul; 104(1):1-11. PubMed ID: 17004107
[TBL] [Abstract][Full Text] [Related]
50. Cellular location of thymus-leukemia (TL) antigen as shown by immuno-cryoultramicrotomy.
Hartfield C; McDowall A; Loveland B; Fischer Lindahl K
J Electron Microsc Tech; 1991 Jun; 18(2):148-56. PubMed ID: 1885998
[TBL] [Abstract][Full Text] [Related]
51. Expression of TL, H-2, and chimeric H-2/TL genes in transgenic mice: abnormal thymic differentiation and T-cell lymphomas in a TL transgenic strain.
Hamasima N; Takahashi T; Taguchi O; Nishizuka Y; Stockert E; Old LJ; Obata Y
Proc Natl Acad Sci U S A; 1989 Oct; 86(20):7995-9. PubMed ID: 2813374
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and processing of molecules bearing thymus leukemia antigen.
Rothenberg E; Boyse EA
J Exp Med; 1979 Oct; 150(4):777-91. PubMed ID: 315985
[TBL] [Abstract][Full Text] [Related]
53. Further polymorphism of the Tla locus defined by monoclonal TL antibodies.
Shen FW; Chorney MJ; Boyse EA
Immunogenetics; 1982; 15(6):573-8. PubMed ID: 7106865
[TBL] [Abstract][Full Text] [Related]
54. Additional products of the Tla locus of the mouse.
Chorney MJ; Shen FW; Tung JS; Boyse EA
Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7044-7. PubMed ID: 3876563
[TBL] [Abstract][Full Text] [Related]
55. Characterization of the thymus leukemia (TL) product encoded by the BALB/c T3c gene by DNA-mediated gene transfer. Comparison to the T13c product and BALB/c leukemia TL.
Chorney MJ; Mashimo H; Bushkin Y; Nathenson SG
J Immunol; 1989 Dec; 143(11):3762-8. PubMed ID: 2584718
[TBL] [Abstract][Full Text] [Related]
56. In vivo modulation of thymus-leukemia antigens on mouse leukemia cells and thymocytes: retention of modulating antibody on the cell surface.
Jacobson JB; Galuska S; Stackpole CW
J Natl Cancer Inst; 1978 Sep; 61(3):819-25. PubMed ID: 80455
[TBL] [Abstract][Full Text] [Related]
57. Lym 7.3: new murine specificity defining third allele of the Ly 7 locus.
Lanier LL; Warner NL
Hybridoma; 1983; 2(2):177-85. PubMed ID: 6205975
[TBL] [Abstract][Full Text] [Related]
58. Genomic constitution of an H-2:Tla variant leukemia.
Shen FW; Chaganti RS; Doucette LA; Litman GW; Steinmetz M; Hood L; Boyse EA
Proc Natl Acad Sci U S A; 1984 Oct; 81(20):6447-50. PubMed ID: 6593710
[TBL] [Abstract][Full Text] [Related]
59. Antigenic modulation in vitro. I. Fate of thymus-leukemia (TL) antigen-antibody complexes following modulation of TL antigenicity from the surfaces of mouse leukemia cells and thymocytes.
Stackpole CW; Jacobson JB; Lardis MP
J Exp Med; 1974 Oct; 140(4):939-53. PubMed ID: 4610077
[TBL] [Abstract][Full Text] [Related]
60. Biochemical genetics of TL antigens.
Michaelson J; Boyse EA; Ciccia L; Flaherty L; Fleissner E; Garnick E; Hämmerling U; Lawrence M; Mauch P; Shen FW
Immunogenetics; 1986; 24(2):103-14. PubMed ID: 2427440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
